← Reading library

Product review · Sources checked 2026-10-01

The Ordinary Retinol 1% in Squalane review: a water-free serum and its open formula fields

The anhydrous preparation, matching 30 ml offer and distinctions from the brand's other retinoids.

Public-source editorial review. No clinician sign-off, firsthand test, personal prescription assessment or supplied-package inspection claimed.

Retinol 1% in Squalane describes a particular kind of preparation: an anhydrous serum supported by squalane. The Ordinary explicitly calls it water-free and does not present it as a cream, even though it appears beside other age-support formulations.

The practical question is what that concise name resolves. This review considers the active, stated format and matching offer before separating them from a complete ingredient declaration, a finished-serum trial and the record for a container that has not been inspected.

Read through the preparation

The format is explicitly anhydrous

The US product page names Retinol 1% in Squalane, displays $9.90 and describes the format as an anhydrous serum. It highlights retinol and squalane and lists appearance-related concerns such as texture and uneven tone. Anhydrous means the advertised preparation is water-free; it does not mean the two headline names are its only components.

This is a retail retinol item rather than a prescribed tretinoin medicine. The vehicle-and-strength guide explains why a form and a concentration need separate descriptions. The manufacturer's precise name is useful without an inference that an oil-like, creamy or water-free format determines clinical effectiveness, personal tolerance or equivalence to a different topical preparation.

Literal base claims are more useful than assumptions

The product's highlights say water-free and alcohol-free, while explicitly saying it is not oil-free. Its narrative identifies 1% retinol and gives squalane a moisture-related role. These statements help describe the advertised base, but the returned product record does not supply a complete ingredient declaration. Highlights and explanation

We therefore cannot turn the short name into a two-ingredient recipe or establish every component absent from the serum. A concern about something outside the highlighted pair needs the applicable full list. The combination-ingredient guide keeps this distinction visible: a rationale for an active alongside a supporting ingredient does not identify all of the finished preparation or prove that it avoids unwanted effects.

The neighboring retinoids have different identities

The Ordinary's brand guide distinguishes retinol, retinal, retinyl esters and Granactive Retinoid. Its product discussion also separates squalane preparations from Granactive Retinoid Emulsion and Retinal Emulsion. Those distinctions prevent the percentages and form names from being pooled into one formulation story.

This review does not adopt the guide's strength progression, application advice or compatibility recommendations. Nor does an ingredient-family explanation establish that one molecule's advertised percentage can be converted into another's prescription strength. The INKEY Starter Serum review examines a separately named product with branded-complex wording. Both records benefit from keeping the exact percentage attached to the exact substance or complex named, rather than assuming that similar numbers describe the same preparation.

The guide supplies a matching quantity

The guide's portfolio area lists Retinol 1% in Squalane at 30 ml and $9.90, matching the named product and price on the US product page. Neighboring items have their own concentrations, sizes and prices. That matching entry supplies a bounded quantity record, not proof that a specific bottle or order was examined. Matching portfolio entry Product offer

A price and quantity can be useful without establishing stock, checkout totals or how long an item would last for a person. The Paula's Choice treatment review separately considers full and travel size records. These commercial fields identify the offer being discussed; they do not provide an application amount, course length or basis for judging value by clinical results.

An ingredient explanation is not the serum's trial

The product narrative attributes appearance improvements to retinol and describes squalane as supporting moisture. The brand guide provides a broader explanation of retinoid families and skin appearance. Neither passage used here supplies an acquired full clinical trial of this complete 1% serum with participant numbers, a comparator and detailed outcomes. Product explanation Family guide

The FTC guidance distinguishes evidence for an isolated ingredient from what is needed to support a complete product claim. Applied here, the presence of retinol cannot transfer another preparation's study findings into this serum. We do not conclude that no research exists; the limit is what was available and actually reviewed for this account.

Its container information belongs to this formulation

The product page contains formulation-specific caution, handling and dating information. Those statements are part of the manufacturer's record for this named serum. They do not establish a universal rule for another retinol product, a compounded cream or the particular container someone has received. We do not reproduce them as reader instructions. Product-specific information

FDA's cosmetic framework concerns intended use and the manufacturer's responsibilities, with cosmetic nonpreapproval and the color-additive exception kept distinct. It does not authenticate the serum or validate its stability. Our container-record guide likewise explains why commercial periods, another label and a visual appearance cannot fill the applicable information for an unexamined preparation.

A concise formula name leaves a concrete question

The record supports a water-free retinol serum with squalane highlighted, a declared 1% retinol figure and a matching 30 ml offer. It does not establish the entire base in the returned product description or confirm an individual label. Those are specific limits rather than a reason to dismiss the useful identity details already supplied. Product record

AAD distinguishes retail retinol from prescription tretinoin and discusses irritation as a matter for professional assessment. The missing full list and a personal concern can be discussed using the exact product name, rather than a generic retinoid comparison. This review gives no routine, percentage conversion, handling protocol or instruction to replace a medicine, and does not equate a familiar active with a predictable response.

Sources for this preparation discussion

  1. The Ordinary Retinol 1% in Squalane ↗Manufacturer US anhydrous serum record; highlights only · Accessed 2026-10-01
  2. The Ordinary retinoid guide ↗Manufacturer separate formulation and matching quantity/price context · Accessed 2026-10-01
  3. FTC: Health Products Compliance Guidance ↗FTC substantiation guidance · Accessed 2026-10-01
  4. FDA: Cosmetics and U.S. Law ↗FDA cosmetics regulatory context · Accessed 2026-10-01
  5. American Academy of Dermatology: retinoid and retinol distinctions ↗Professional society public guidance, updated May 25, 2021; family identity and irritation context, not individualized directions · Accessed 2026-10-01
Read the complete source register →